Literature DB >> 14651564

Validation of a Cantonese version of the Children's Dermatology Life Quality Index.

Antonio A T Chuh1.   

Abstract

My goal was to assess the validity and reliability of a Cantonese version of the Children's Dermatology Life Quality Index (CDLQI). To do so, I invited four translators to produce a proper Cantonese translation of the CDLQI. I asked five children to complete this version and made adjustments as necessary. I then requested 30 children with skin problems and 30 children consulting for problems unrelated to the skin in a primary care setting to complete the questionnaire before their consultation. A physician assessed the severity of the skin problem using a visual analog scale. Some children from both groups completed the questionnaire again 7 days later. The CDLQI scores are strongly (gammas = 0.850) and significantly (p < 0.01) correlated with physician-rated disease severity. The Cantonese CDLQI scores were similar to those of the English version for individual skin problems. Correlation of test-retest results is strong (gammas = 0.958, p < 0.01). Cronbach's alpha is 0.83. I concluded that the Cantonese CDLQI is a valid and reliable tool for assessing the effects of skin problems on quality of life in children.

Entities:  

Mesh:

Year:  2003        PMID: 14651564     DOI: 10.1111/j.1525-1470.2003.20604.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  9 in total

1.  Psychometric properties and gender invariance of the Chinese version of the self-report Pediatric Quality of Life Inventory version 4.0: short form is acceptable.

Authors:  Chung-Ying Lin; Wei-Ming Luh; Ai-Lun Yang; Chia-Ting Su; Jung-Der Wang; Hui-Ing Ma
Journal:  Qual Life Res       Date:  2011-05-15       Impact factor: 4.147

2.  CDLQI, SCORAD and NESS: are they correlated?

Authors:  K L E Hon; W Y C Kam; M C A Lam; T F Leung; P C Ng
Journal:  Qual Life Res       Date:  2006-07-07       Impact factor: 4.147

Review 3.  Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.

Authors:  Balvinder Rehal; April W Armstrong; April Armstrong
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

4.  Factor structure of the Singapore English version of the KINDL children quality of life questionnaire.

Authors:  Hwee-Lin Wee; Ulrike Ravens-Sieberer; Michael Erhart; Shu-Chuen Li
Journal:  Health Qual Life Outcomes       Date:  2007-01-19       Impact factor: 3.186

Review 5.  Dismissing the fallacies of childhood eczema management: case scenarios and an overview of best practices.

Authors:  Kam Lun Hon; Kin Fon Leong; Theresa Nh Leung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2018-12-03

6.  Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers.

Authors:  Kam Lun Hon; Kathy Yin Ching Tsang; Jeng Sum C Kung; Ting Fan Leung; Christopher W K Lam; Chun Kwok Wong
Journal:  Molecules       Date:  2017-02-14       Impact factor: 4.411

7.  Efficacy of the integrative Body-Mind-Spirit group intervention for improving quality of life in parent-child dyads adjusting to atopic dermatitis: protocol for a randomised controlled trial.

Authors:  Victoria Ka Ying Hui; Celia Hoi Yan Chan; Yat Lui Fung; Cecilia Lai Wan Chan; Martha Sin Ki Luk
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

8.  Patient-Reported Outcome Measures in Dermatology: A Systematic Review.

Authors:  Rachael L Pattinson; Nirohshah Trialonis-Suthakharan; Sunnia Gupta; Alasdair L Henry; Jacqueline F Lavallée; Marina Otten; Timothy Pickles; Nick Courtier; Jennifer Austin; Christine Janus; Matthias Augustin; Chris Bundy
Journal:  Acta Derm Venereol       Date:  2021-09-28       Impact factor: 3.875

9.  Measuring the quality of life of the families of children with eczema in Hong Kong.

Authors:  Nam Sze Cheng; Pak Chun Janita Chau; Kam Lun Ellis Hon; Kai Chow Choi; Jeng Sum Charmaine Kung; Wing Gi Ng; Ting Fan Leung
Journal:  Asia Pac Allergy       Date:  2019-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.